Primary Site >> Stomach Cancer
Gene >> NLRP3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Histologic, immunohistochemical and morphometric study of the mucosa of the total gastric antrum in patients with carcinoma of the stomach. PMID: 8093984 |
Ref: Activation of ASC induces apoptosis or necrosis, depending on the cell type, and causes tumor eradication. PMID: 20500518 |
Ref: Mycoplasma hyorhinis activates the NLRP3 inflammasome and promotes migration and invasion of gastric cancer cells. PMID: 24223129 Ref: Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells. PMID: 24280762 |
Ref: The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses. PMID: 24901306 Ref: Pattern-recognition receptors and gastric cancer. PMID: 25101079 Ref: Helicobacter pylori-induced IL-1beta secretion in innate immune cells is regulated by the NLRP3 inflammasome and requires the cag pathogenicity island. PMID: 25172489 |
Ref: Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18. PMID: 25742401 Ref: Withaferin A Inhibits Helicobacter pylori-induced Production of IL-1beta in Dendritic Cells by Regulating NF-kappaB and NLRP3 Inflammasome Activation. PMID: 26770181 |
Ref: Helicobacter pylori induces IL-1beta protein through the inflammasome activation in differentiated macrophagic cells. PMID: 26912137 Ref: Inflammasome Activation by Helicobacter pylori and Its Implications for Persistence and Immunity. PMID: 27460807 |
Ref: Redox signaling in the gastrointestinal tract. PMID: 28062361 Ref: Inflammasomes and Cancer. PMID: 28093447 Ref: Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells. PMID: 28367997 Ref: Yes, research matters. PMID: 28796840 |
Ref: MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis. PMID: 29059152 Ref: NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents. PMID: 29076433 |